Trial Profile
A phase I trial of GLPG 2451 in healthy volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 May 2016
Price :
$35
*
At a glance
- Drugs GLPG 2451 (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions
- Sponsors Galapagos NV
- 14 May 2016 New trial record
- 09 May 2016 According to a Galapagos NV media release, top-line results are expected in the fourth quarter of 2016.